Clinical trial
Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic…
NCT00389480 · Arno Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00389480 |
|---|---|
| Title | Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies |
| Official title | A Phase I Study of DB-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) in Adult Patients With Refractory or Metastatic Solid Malignancies |
| Lead sponsor | Arno Therapeutics, Industry |
| Collaborators | University of Kentucky Arch Medical Services Inc., DBA The Center for Cancer Care and Research Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | AR-67 (formerly DB-67) |
| Enrollment | 26 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Oct 18, 2006 |
| Last update posted | Aug 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: